Delta Life Science

Delta Life Science, formerly known as Delta Diagnostics, is a Netherlands-based life science tools and diagnostics company developing label-free, multiplexed biosensing instruments based on integrated photonics. Founded in 2018 as a spin-out from TNO, the company commercializes patented nanophotonic biosensor technology for real-time analysis of biomolecular interactions without labels or tags. Its lead commercial product, inQuiQ®, is aimed at assay developers, academic researchers, and pharmaceutical scientists for applications including biomarker validation, drug discovery, and assay development. The company positions its platform as a compact, lower-cost alternative to incumbent biosensing systems, with capabilities in multiplexing and analysis of complex matrices such as serum and plasma. Delta Life Science has raised Series A financing and appears to be actively commercializing its first instrument while developing a higher-throughput follow-on system.